Amsterdam, The Netherlands -- January 5, 2023. Elsevier and the ESG, Agency for Publishing and Internet Services, are delighted to announce a new partnership to publish the International Journal of Electrochemical Science (IJOES).
IJOES is an open access journal and published papers will immediately and permanently be available for everyone to read, download, copy, and distribute. The journal will be hosted on Elsevier's leading online platform, ScienceDirect, beginning January 2023.
"Given that electrochemistry occupies a significant place in modern science, the main goal of IJOES is to provide validated scientific information which will be useful for readers, institutions and societies interested in this field of research. Developments in electrochemistry is reflected in numerous modern-day research. For instance, findings on new anodic and cathodic materials are used in numerous batteries, and research of materials for varieties of sensors, organic synthesis, electrometallurgy and in managing the corrosion of materials. Therefore, the mission of IJOES is of great significance for those fields of research." said Professor Milan Antonijevic, Editor-in-Chief of IJOES.
"The partnership with Elsevier will bring great benefits to the development and reputation of the International Journal of Electrochemical Science given that Elsevier is a leading scientific publisher, and at the same time it will be a great honour for us. We are grateful to all from Elsevier's team who worked on making this partnership possible."
About the International Journal of Electrochemical Science and ESG
IJOES started publishing in 2006 as an open access journal. Scientists from more than 4200 institutions and universities from more than 100 countries around the world have chosen to publish their research with us. The journal publishes research articles, review articles and short communications on topics covering the full range of electrochemistry research. ESG is an agency for publishing and internet services and it publishes IJOES; having developed and run the journal from its earliest days.
About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com.